| International research networks in pharmaceuticals: Structure and dynamics U Cantner, B Rake Research Policy 43 (2), 333-348, 2014 | 97 | 2014 |
| Collaboration in pharmaceutical research: Exploration of country-level determinants T Plotnikova, B Rake Scientometrics 98 (2), 1173-1202, 2014 | 86 | 2014 |
| Repurposing without purpose? Early innovation responses to the COVID‐19 crisis: Evidence from clinical trials M Hanisch, B Rake R&D Management 51 (4), 393-409, 2021 | 32 | 2021 |
| Product innovation success based on cancer research in the pharmaceutical industry: co-publication networks and the effects of partners M McKelvey, B Rake Industry and Innovation 23 (5), 383-406, 2016 | 31 | 2016 |
| The changing geography of clinical research: a critical analysis of its drivers C Haeussler, B Rake Industrial and Corporate Change 26 (2), 285-310, 2017 | 26 | 2017 |
| Exploring scientific publications by firms: what are the roles of academic and corporate partners for publications in high reputation or high impact journals? M McKelvey, B Rake Scientometrics 122 (3), 1323-1360, 2020 | 17 | 2020 |
| Determinants of pharmaceutical innovation: the role of technological opportunities revisited B Rake Journal of Evolutionary Economics 27 (4), 691-727, 2017 | 15* | 2017 |
| Exploring network dynamics in science: the formation of ties to knowledge translators in clinical research B Rake, P D’Este, M McKelvey Journal of Evolutionary Economics 31 (5), 1433-1464, 2021 | 9 | 2021 |
| Do publication activities of academic institutions benefit from formal collaborations with firms? B Rake Innovation 23 (2), 241-265, 2021 | 9 | 2021 |
| Did relaxing clinical trial regulation enhance the stock of scientific knowledge in India? Not necessarily B Rake, C Haeussler PloS one 14 (1), e0210163, 2019 | 7 | 2019 |
| Waiving intellectual property rights: Boom or bust for medical innovation? B Rake Drug Discovery Today 27 (2), 384-389, 2022 | 6 | 2022 |
| International research networks in pharmaceuticals: Structure and dynamics U Cantner, B Rake Jena economic research papers, 2011 | 6 | 2011 |
| Collaboration in pharmaceutical research: Exploration of country-level determinants T Plotnikova, B Rake Jena economic research papers, 2011 | 4 | 2011 |
| Doing science together: gaining momentum from long-term explorative university–industry research programs B Rake, K Sengupta, L Lewin, A Sandström, M McKelvey Drug Discovery Today, 103687, 2023 | 3 | 2023 |
| Geography of authorship: How geography shapes authorship attribution in big team science J Hoekman, B Rake Research Policy 53 (2), 104927, 2024 | 2 | 2024 |
| How do networks affect knowledge generation for drug development? B Rake, P D'Este, M McKelvey, A Assmus Academy of Management Proceedings 2017 (1), 15393, 2017 | 2 | 2017 |
| Research network position and innovative performance: Evidence from the pharmaceutical industry M McKelvey, B Rake Jena Economic Research Papers, 2012 | 2 | 2012 |
| Repurposing: A collaborative innovation strategy for the digital age B Rake, M Hanisch The PDMA Handbook of Innovation and New Product Development 103, 2023 | 1 | 2023 |
| Controversies with Clinical Trial Regulations in Low-and Middle-Income Countries B Rake Integrity of Scientific Research: Fraud, Misconduct and Fake News in the …, 2022 | 1 | 2022 |
Maureen MckelveyProfessor of Industrial Management, University of GothenburgVerifierad e-postadress på handels.gu.se
